UN health agency issues alert on falsified semaglutides used for diabetes treatment, weight loss | UN News

The World Health Organization (WHO) on Thursday issued a medical product alert on the release of three batches of falsified semaglutides – brand name Ozempic – the type of medicines primarily used to treat type 2 diabetes and obesity in some countries.